Rapid Diagnosis of Intrahepatic Cholestasis of Pregnancy (ICP): Validation of an Automated Enzymatic Total Bile Acid Assay and Assessment of Ursodeoxycholic Acid Impact on Bile Acid Profiles in an ICP Cohort
The Journal of Applied Laboratory Medicine · 04.11.2026 · 11 (6) · 1442-1451
DOI: 10.1093/jalm/jfag099 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift The Journal of Applied Laboratory Medicine, online erschienen am 29.06.2026. Verfasst von Jillian Kodger und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, United States. Hauptthemen laut MEDLINE: Cholestasis, Intrahepatic, Ursodeoxycholic Acid, Bile Acids and Salts, Pregnancy Complications. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Judd's Legacy, Judd’s Legacy.
Abstract (Originalsprache)
Background
Intrahepatic cholestasis of pregnancy (ICP) requires timely diagnosis to guide management, including initiation of ursodeoxycholic acid (UDCA) and delivery planning. LC-MS/MS provides fractionated bile acid profiles but has a turnaround time (TAT) of approximately 1 week, delaying treatment. Enzymatic total bile acid (TBA) assays offer faster results but measure all bile acids collectively, which some have reported can be impacted by UDCA treatment.
Methods
We validated the Diazyme enzymatic TBA assay on a Roche Cobas analyzer, assessing analytical measurement range, reference interval, precision, and accuracy vs LC-MS/MS. The comparison cohort included samples from 100 pregnant patients (median age 31 years; gestational age 34 weeks) presenting with pruritus and suspected of ICP. A secondary analysis examined UDCA and tauroursodeoxycholic acid in a UDCA-detectable subset. TAT was evaluated retrospectively in 971 specimens.
Results
We verified the assay’s analytical measurement range of 1 to 180 µmol/L and reference interval of <10 µmol/L. Precision was <10%, and method comparison revealed minimal bias, with 98% clinical concordance. In the UDCA subset (n = 19), UDCA and tauroursodeoxycholic acid represented minor fractions of total TBA. Operationally, the enzymatic assay provided rapid results, with a median TAT of 5.6 h from collection (range 0.6–36.8) and 0.5 h from receipt (range 0.2–22.3); delays were mainly due to transport.
Conclusions
The Diazyme enzymatic TBA assay on Roche Cobas demonstrates robust performance and rapid turnaround, supporting timely ICP diagnosis and management. LC-MS/MS remains useful for fractionated profiling but is limited by longer TAT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, United States.
- Department of Pathology and Laboratory Medicine, University of Kentucky College of Medicine, Lexington, KY, United States.
- Department of Laboratory Medicine, Yale New Haven Hospital, New Haven, CT, United States.
ORCID-Profile: Ibrahim Choucair, Joe M El-Khoury
Förderung
- Judd's Legacy
- Judd’s Legacy
Zitieren
APA
Kodger, J., Nadim, H., Choucair, I., Sutphin, A., Eid, T., & El-Khoury, J. M. (2026). Rapid Diagnosis of Intrahepatic Cholestasis of Pregnancy (ICP): Validation of an Automated Enzymatic Total Bile Acid Assay and Assessment of Ursodeoxycholic Acid Impact on Bile Acid Profiles in an ICP Cohort. The Journal of Applied Laboratory Medicine, 11(6), 1442-1451. https://doi.org/10.1093/jalm/jfag099
Vancouver
Kodger J, Nadim H, Choucair I, Sutphin A, Eid T, El-Khoury JM. Rapid Diagnosis of Intrahepatic Cholestasis of Pregnancy (ICP): Validation of an Automated Enzymatic Total Bile Acid Assay and Assessment of Ursodeoxycholic Acid Impact on Bile Acid Profiles in an ICP Cohort. The Journal of Applied Laboratory Medicine. 2026;11(6):1442-1451. doi:10.1093/jalm/jfag099
BibTeX
@article{Kodger2026,
author = {Kodger, Jillian and Nadim, Haleh and Choucair, Ibrahim and Sutphin, Angela and Eid, Tore and El-Khoury, Joe M},
title = {Rapid Diagnosis of Intrahepatic Cholestasis of Pregnancy (ICP): Validation of an Automated Enzymatic Total Bile Acid Assay and Assessment of Ursodeoxycholic Acid Impact on Bile Acid Profiles in an ICP Cohort},
journal = {The Journal of Applied Laboratory Medicine},
year = {2026},
volume = {11},
number = {6},
pages = {1442--1451},
doi = {10.1093/jalm/jfag099}
}
EUVIMED